Neidig L. Brent's most recent trade in Usana Health Sciences Inc was a trade of 4,743 Common Stock done at an average price of $32.3 . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.34 per share. | 12 Mar 2025 | 4,743 | 0 (0%) | 0% | 32.3 | 153,387 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 26,986 | 43,894 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 3,689 | 6,380 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 3,689 | 16,908 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 1,637 | 4,743 (0%) | 0% | 30.6 | 50,174 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,459 | 3,339 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,459 | 20,597 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 648 | 2,691 (0%) | 0% | 30.6 | 19,861 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,220 | 2,220 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,220 | 23,458 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,402 | 22,056 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,402 | 2,519 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 1,103 | 1,117 (0%) | 0% | 31.2 | 34,425 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 639 | 1,880 (0%) | 0% | 30.6 | 19,585 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO. & MAN. DIR. OF CHINA | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 06 Mar 2024 | 3,810 | 0 (0%) | 0% | 47.0 | 179,066 | Common Stock |
| Usana Health Sciences Inc | L. Brent Neidig | CO. & MAN. DIR. OF CHINA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 14,757 | 25,678 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | L. Neidig Brent | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,459 | 10,921 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | L. Neidig Brent | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,459 | 4,458 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Neidig Brent L. | CO. & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.85 per share. | 08 Feb 2024 | 648 | 3,810 (0%) | 0% | 50.9 | 32,951 | Common Stock |
| Usana Health Sciences Inc | Brent Neidig L. | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,220 | 13,781 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,220 | 3,205 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Neidig L. Brent | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,401 | 12,380 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Neidig L. Brent | CO. & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,401 | 3,621 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | L. Brent Neidig | CO. & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.80 per share. | 06 Feb 2024 | 985 | 2,220 (0%) | 0% | 47.8 | 47,083 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO. & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.71 per share. | 06 Feb 2024 | 622 | 2,999 (0%) | 0% | 49.7 | 30,920 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,915 | 16,001 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Neidig L. Brent | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,915 | 1,915 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | L. Brent Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.23 per share. | 03 Feb 2024 | 930 | 985 (0%) | 0% | 47.2 | 43,924 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Sale of securities on an exchange or to another person at price $ 66.96 per share. | 05 May 2023 | 2,694 | 0 (0%) | 0% | 67.0 | 180,389 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 467 | 17,916 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 467 | 2,902 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.37 per share. | 29 Apr 2023 | 208 | 2,694 (0%) | 0% | 66.4 | 13,805 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Sale of securities on an exchange or to another person at price $ 61.89 per share. | 09 Feb 2023 | 1,872 | 2,435 (0%) | 0% | 61.9 | 115,864 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 8,879 | 21,244 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,459 | 18,383 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,459 | 4,955 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,402 | 19,842 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,402 | 4,118 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.53 per share. | 06 Feb 2023 | 648 | 4,307 (0%) | 0% | 61.5 | 39,871 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 06 Feb 2023 | 622 | 3,496 (0%) | 0% | 59.8 | 37,171 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,914 | 12,870 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,914 | 3,320 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 885 | 2,435 (0%) | 0% | 60.0 | 53,135 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 505 | 12,365 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 505 | 2,940 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 224 | 2,716 (0%) | 0% | 60.0 | 13,449 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Sale of securities on an exchange or to another person at price $ 70.93 per share. | 16 Jun 2022 | 1,400 | 1,406 (0%) | 0% | 70.9 | 99,302 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 468 | 14,784 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 468 | 3,014 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | CO & MAN. DIR. OF CHINA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.66 per share. | 29 Apr 2022 | 208 | 2,806 (0%) | 0% | 76.7 | 15,945 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 5,606 | 16,711 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,459 | 3,194 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,459 | 15,252 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. | 07 Feb 2022 | 648 | 2,546 (0%) | 0% | 94.3 | 61,106 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,915 | 12,311 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,915 | 1,915 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.82 per share. | 03 Feb 2022 | 850 | 1,065 (0%) | 0% | 93.8 | 79,747 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 702 | 11,105 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 702 | 2,047 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 504 | 11,807 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 504 | 1,569 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 312 | 1,735 (0%) | 0% | 92.3 | 28,804 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 224 | 1,345 (0%) | 0% | 92.3 | 20,680 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 05 Nov 2021 | 175 | 0 (0%) | 0% | 102.9 | 18,004 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 315 | 14,226 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 315 | 315 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.84 per share. | 23 Oct 2021 | 140 | 175 (0%) | 0% | 99.8 | 13,978 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Sale of securities on an exchange or to another person at price $ 102.17 per share. | 18 Jun 2021 | 259 | 0 (0%) | 0% | 102.2 | 26,462 | Common |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 467 | 467 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 467 | 14,541 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.64 per share. | 29 Apr 2021 | 208 | 260 (0%) | 0% | 87.6 | 18,229 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Sale of securities on an exchange or to another person at price $ 90.78 per share. | 12 Feb 2021 | 2,044 | 0 (0%) | 0% | 90.8 | 185,561 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2021 | 5,836 | 15,008 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 283 | 2,170 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 283 | 9,172 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 06 Feb 2021 | 126 | 2,044 (0%) | 0% | 84.2 | 10,609 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,915 | 1,915 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,915 | 10,933 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 03 Feb 2021 | 850 | 1,065 (0%) | 0% | 82.8 | 70,346 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 701 | 2,198 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 701 | 9,455 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 505 | 1,570 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 505 | 10,428 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 03 Feb 2021 | 311 | 1,887 (0%) | 0% | 84.2 | 26,186 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 272 | 1,618 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 272 | 10,156 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 224 | 1,346 (0%) | 0% | 85.2 | 19,080 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 121 | 1,497 (0%) | 0% | 85.2 | 10,307 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 315 | 12,848 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 315 | 315 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Sale of securities on an exchange or to another person at price $ 84.81 per share. | 23 Oct 2020 | 175 | 0 (0%) | 0% | 84.8 | 14,841 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.86 per share. | 23 Oct 2020 | 140 | 175 (0%) | 0% | 85.9 | 12,020 | Common Stock |
| Usana Health Sciences Inc | Brent L. Neidig | Chief Officer & MD of China | Sale of securities on an exchange or to another person at price $ 83.75 per share. | 13 Aug 2020 | 260 | 0 (0%) | 0% | 83.8 | 21,776 | Common Stock |